Where it appears, on the occasion of a decision to suspend or prohibit an activity relating to a product or group of products taken by the National Agency for the Safety of Medicines and Health Products pursuant to Article L. 5312-1, that all or part of the activities of the natural or legal person concerned are being carried out under conditions presenting a proven risk to human health, the Agency may order the suspension of all or part of these activities for the time necessary to implement measures to eliminate this risk, up to a maximum of six months.
Except in emergencies, the suspension decision referred to in the first paragraph may only be taken after the natural or legal person has been given the opportunity to present its observations.
If, at the end of the period of suspension referred to in the first paragraph, the person concerned has not taken the appropriate measures to eliminate the risk, the Agency may, after a new inspection, issue a new suspension under the same conditions.